ESCC
Clinical trials for ESCC explained in plain language.
Never miss a new study
Get alerted when new ESCC trials appear
Sign up with your email to follow new studies for ESCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat cancers: experimental drug NRM-823 enters human trials
Disease control Recruiting nowThis early-phase study tests whether a new drug called NRM-823 is safe and can help people with advanced solid tumors that have not responded to other treatments. About 150 adults with cancers like lung, ovarian, or triple-negative breast cancer will receive NRM-823 alone or with…
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: Normunity AccelCo, Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New drug JAB-8263 tested in advanced cancers – hope for hard-to-treat tumors
Disease control Recruiting nowThis early-stage trial tests a new drug called JAB-8263 in adults with advanced solid tumors (like lung, ovarian, or esophageal cancer) or blood cancers (like leukemia). The goal is to find a safe dose and see if it can shrink tumors. About 152 people whose cancer has worsened af…
Matched conditions: ESCC
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New combo therapy before surgery shows promise for esophageal cancer patients
Disease control Recruiting nowThis study tests a new approach for people with locally advanced esophageal cancer. Participants receive a combination of immunotherapy and chemotherapy, followed by chemoradiation, and then surgery. The goal is to see if this sequence can shrink tumors more effectively and impro…
Matched conditions: ESCC
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug ALX2004 targets tough cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called ALX2004 in people with advanced or metastatic solid tumors (lung, head and neck, colorectal, or esophageal cancer) that have not responded to standard treatments. ALX2004 is an antibody-drug conjugate designed to deliver a cancer-kil…
Matched conditions: ESCC
Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
Simple blood test could spot deadly esophageal cancer before It's too late
Diagnosis Recruiting nowThis study aims to create a simple blood test to find esophageal cancer early, when it's easier to treat. Researchers will look at tiny particles in the blood of 600 adults with and without the cancer. If successful, this test could replace invasive procedures like endoscopy for …
Matched conditions: ESCC
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 01, 2026 15:57 UTC